SCHEDULE 13G/A: Morgan Stanley Discloses 12.2% Passive Stake in agilon health, Inc. via Amended Schedule 13G

Morgan Stanley and its wholly-owned subsidiary, Morgan Stanley Investment Management Inc., have filed an amended Schedule 13G disclosing a combined beneficial ownership of 12.2% of agilon health, Inc.'s common stock as of March 31, 2025.

Summary

• Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., collectively beneficially own 12.2% of agilon health, Inc.'s common stock.
• This filing is an Amendment No. 5 to a Schedule 13G, indicating a change in their previously reported beneficial ownership that triggered an updated disclosure.
• As of March 31, 2025, Morgan Stanley reported aggregate beneficial ownership of 50,200,249 shares, while Morgan Stanley Investment Management Inc. reported 50,129,429 shares.
• The ownership is primarily through shared voting and dispositive power, reflecting their roles as a parent holding company and an investment adviser.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of agilon health, Inc.

Sentiment

Score: 6

Explanation: The document is neutral in tone as it is a factual disclosure of beneficial ownership. The presence of a large institutional investor like Morgan Stanley can be seen as a positive signal of confidence, hence slightly above neutral.

Positives

• The disclosure of a significant 12.2% stake by a major financial institution like Morgan Stanley can signal confidence in agilon health, Inc.'s long-term prospects.
• The passive nature of the investment, as indicated by the Schedule 13G filing, suggests it is part of routine portfolio management rather than an activist stance, which can be viewed as a stable investment.

Risks

• The document notes that intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding agilon health, Inc.'s future performance or outlook. It solely reports beneficial ownership as of a specific date.

Management Comments

• Morgan Stanley and Morgan Stanley Investment Management Inc. certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of agilon health, Inc.

Industry Context

This filing reflects a routine disclosure of a significant passive institutional investment in a healthcare services company. Large institutional holdings are common in the healthcare sector, which often attracts long-term investors due to its defensive characteristics and growth potential. The filing itself does not provide specific industry trends but indicates continued institutional interest in agilon health, Inc.

Comparison to Industry Standards

• As a Schedule 13G filing, this document primarily serves as a disclosure of beneficial ownership and does not provide performance metrics for direct comparison to industry standards.
• The significant stake held by a major financial institution like Morgan Stanley is consistent with typical institutional investment patterns in established public companies within the healthcare sector.
• There are no specific comparable companies, projects, or results mentioned in this filing to allow for a detailed performance comparison.

Stakeholder Impact

• Shareholders: Provides increased transparency regarding significant institutional holdings. The presence of a large, passive institutional investor may provide a sense of stability.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is mentioned or implied by this ownership disclosure.

Next Steps

• The document does not outline any specific future actions or milestones for agilon health, Inc. or the reporting persons beyond the ongoing requirement to file amendments to Schedule 13G if there are material changes in beneficial ownership.

Key Dates

Keywords

agilon health, Morgan Stanley, Schedule 13G, beneficial ownership, common stock, institutional investment, passive stake, healthcare services, investment management